FDA Clears AI for Heart Procedure Planning
DASI Simulations' AI gains FDA clearance, aiding TAVR planning and boosting cardiology's role in healthcare AI.
- Latest
- Trending
DASI Simulations' AI gains FDA clearance, aiding TAVR planning and boosting cardiology's role in healthcare AI.
Automated insulin delivery tech helps T1D runners manage glucose during marathons, enhancing safety and performance.
OpenAI launches AI models with advanced reasoning, improving problem-solving in science, coding, and math.
Crypto analyst Justin Bennett warns Bitcoin's four-year cycle may end due to macroeconomic changes.
Adobe's Q3 earnings exceeded forecasts with EPS of $4.65 and revenue of $5.41B, surpassing analyst predictions.
Virchow, developed by Paige, detects rare cancers with 94% accuracy, transforming cancer diagnosis and patient outcomes.
Navient to pay $120M and face US student loan ban to resolve CFPB lawsuit over lending failures and borrower mistreatment.
Discover why Amazon is Berkshire Hathaway's leading AI stock with unmatched innovation and growth potential.
U.S. Bitcoin ETFs saw $1.2B outflows, longest streak yet, but experts say it's a sign of healthy growth.
RTX explores alternatives to China suppliers amid labor shortages and geopolitical risks in the aerospace industry.
We are building the future together with you. We write content with maximum speed and excellent quality. Each material is accompanied by an analyst's commentary.